Tifluadom

Tifluadom is a benzodiazepine derivative that acts as a selective opioid receptor agonist. It is primarily used in scientific research to study the opioid system and its effects on the central nervous system.
Chemical Properties[edit]
Tifluadom is characterized by its unique chemical structure, which includes a trifluoromethyl group. This structural feature contributes to its pharmacological activity and distinguishes it from other benzodiazepines. The presence of the trifluoromethyl group is believed to enhance its binding affinity to opioid receptors.
Mechanism of Action[edit]
Tifluadom acts as an agonist at the kappa-opioid receptors (KOR), which are one of the three main classes of opioid receptors, the others being mu and delta receptors. Activation of KOR by tifluadom leads to a variety of physiological effects, including analgesia, dysphoria, and diuresis.
Pharmacological Effects[edit]
The primary effects of tifluadom are mediated through its action on the kappa-opioid receptors. These effects include:
- Analgesia: Tifluadom produces pain relief by modulating the perception of pain in the central nervous system.
- Dysphoria: Unlike mu-opioid receptor agonists, kappa-opioid receptor agonists like tifluadom can induce feelings of unease or dysphoria.
- Diuresis: Tifluadom can increase urine production by affecting the renal system.
Research Applications[edit]
Tifluadom is used extensively in research to explore the role of kappa-opioid receptors in various physiological and pathological processes. Studies involving tifluadom have contributed to a better understanding of the opioid system and its potential therapeutic targets for conditions such as pain, addiction, and mood disorders.
Safety and Toxicity[edit]
As a research chemical, tifluadom is not approved for human use outside of controlled laboratory settings. Its safety profile in humans is not well-established, and it is primarily handled by trained professionals in research environments.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian